Interplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expression

Area of Science:

• Molecular Biology
• Cancer Research
• Gene Regulation

Background:

• E-cadherin expression is crucial for cell adhesion and is often downregulated in cancer.
• ZEB2/SIP1 and KLF4 are known to oppositely regulate E-cadherin expression.
• These transcription factors may interact at the E-cadherin gene promoter.

Purpose of the Study:

• To investigate the potential competition between ZEB2 and KLF4 for binding to the E-cadherin promoter.
• To identify the specific region of the E-cadherin promoter involved in KLF4-mediated activation.
• To understand how the interplay between ZEB2 and KLF4 affects E-cadherin expression in cancer cells.

Main Methods:

• Analysis of ZEB2 and KLF4 expression levels in breast cancer cell lines.
• Chromatin immunoprecipitation assays to assess KLF4 recruitment to the E-cadherin promoter.
• Reporter gene assays using E-cadherin promoter constructs with deletions or mutations.
• Doxycycline-induced expression of ZEB2 in A431/HA.ZEB2 cells.

Main Results:

• An inverse correlation was observed between ZEB2 levels and KLF4 recruitment to the E-cadherin promoter.
• A critical KLF4 binding region (-28 to -10) was identified within the E-cadherin promoter, essential for KLF4-induced activation.
• This region overlaps with a ZEB2 binding site; deletion of the ZEB2 binding site enhanced KLF4-driven promoter activity.
• ZEB2 expression negatively impacts KLF4's ability to activate E-cadherin promoter activity.

Conclusions:

• ZEB2 and KLF4 compete for binding to a critical region of the E-cadherin promoter.
• The balance of ZEB2 and KLF4 expression levels dictates E-cadherin expression in cancer cells.
• This competition mechanism offers a new perspective on the regulation of E-cadherin in cancer progression.